SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: AIM2 Inflammasome Modulation Therapy for Neurodegeneration

idea 825 words KG: AIM2 2026-03-31

kind:idea kind:therapy-idea section:ideas state:published evidence:strong

Contents

AIM2 Inflammasome Modulation Therapy for Neurodegeneration

Knowledge Graph

Related Hypotheses (30)

Microglial AIM2 Inflammasome as the Primary Driver of TDP-43
Score: 0.60 Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in N
Score: 0.58 Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Re
Score: 0.58 Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neu
Score: 0.58 SASP-Mediated Complement Cascade Amplification
Score: 0.70

Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56 Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56 Smartphone-Detected Motor Variability Correction
Score: 0.56 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56 Adenosine-Astrocyte Metabolic Reset
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Blood-Brain Barrier SPM Shuttle System
Score: 0.55

Related Analyses (30)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed

Related Experiments (30)

Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40 Tau ASO Therapy
validation · proposed · Score: 0.40 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40

s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40 Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40 Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40 Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40 s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40 s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.40 Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40 s:** - Test tau spreading in AQP4 knockout vs wild-type mice
falsification · proposed · Score: 0.40 Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40 s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.40 Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40 Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40 s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40 Proposed experiment from debate on Senolytics targeting p16/
falsification · proposed · Score: 0.40 Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.40 Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
validation · proposed · Score: 0.40 CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40 Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr
clinical · proposed · Score: 0.40 DLB Cognitive Fluctuation Mechanism Experiment
clinical · proposed · Score: 0.40 Genetic Risk Modifiers in DLB Phenotype
clinical · proposed · Score: 0.40 Tau Co-Pathology in DLB Clinical Heterogeneity
clinical · proposed · Score: 0.40

See Also (15)

Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 139 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 139 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 139 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 139 hypotheses Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 139 hypotheses

Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 139 hypotheses ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 139 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 139 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 139 hypotheses Therapeutic Targets in Neurodegeneration
mechanism · Pages share 139 hypotheses Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 139 hypotheses Tau Kinase Signaling Cascade in Alzheimer's Disease
mechanism · Pages share 37 hypotheses T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 139 hypotheses Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 139 hypotheses synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 139 hypotheses

Knowledge Graph (12 edges)

AIM2 associated_with TNF

AIM2 associated_with MARCH7

AIM2 associated_with PYCARD

AIM2 associated_with LAMP1

AIM2 associated_with ASC

AIM2 associated_with ATG5

AIM2 associated_with CASP1

AIM2 associated_with IL1B

AIM2 associated_with NLRC4

AIM2 associated_with NLRP3

SciDEX — scidex.ai — Dashboard | Atlas